HomeCompareFSPKF vs VIG

FSPKF vs VIG: Dividend Comparison 2026

FSPKF yields 1.53% · VIG yields 1.61%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FSPKF wins by $1.3K in total portfolio value· pulled ahead in Year 10
10 years
FSPKF
FSPKF
● Live price
1.53%
Share price
$23.02
Annual div
$0.35
5Y div CAGR
31.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$33.6K
Annual income
$3,544.59
Full FSPKF calculator →
VIG
Vanguard Dividend Appreciation ETF
● Live price
1.61%
Share price
$215.06
Annual div
$3.45
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32.3K
Annual income
$175.21
Full VIG calculator →

Portfolio growth — FSPKF vs VIG

📍 FSPKF pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFSPKFVIG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FSPKF + VIG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FSPKF pays
VIG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FSPKF
Annual income on $10K today (after 15% tax)
$130.35/yr
After 10yr DRIP, annual income (after tax)
$3,012.90/yr
VIG
Annual income on $10K today (after 15% tax)
$136.50/yr
After 10yr DRIP, annual income (after tax)
$148.93/yr
At 15% tax rate, FSPKF beats the other by $2,863.97/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FSPKF + VIG for your $10,000?

FSPKF: 50%VIG: 50%
100% VIG50/50100% FSPKF
Portfolio after 10yr
$33.0K
Annual income
$1,859.90/yr
Blended yield
5.64%
📊

Analyst Conviction Gap

Where Wall Street is split right now

FSPKF
No analyst data
Price Target
$23.65
+2.7% upside vs current
Range: $21.30 — $26.00
Altman Z
26.1
Piotroski
7/9
VIG
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FSPKF buys
0
VIG buys
0
No recent congressional trades found for FSPKF or VIG in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFSPKFVIG
Forward yield1.53%1.61%
Annual dividend / share$0.35$3.45
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR31.2%0%
Portfolio after 10y$33.6K$32.3K
Annual income after 10y$3,544.59$175.21
Total dividends collected$11.9K$1.7K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: FSPKF vs VIG ($10,000, DRIP)

YearFSPKF PortfolioFSPKF Income/yrVIG PortfolioVIG Income/yrGap
1$10,901$201.19$11,301$160.59$400.00VIG
2$11,933$268.93$12,752$162.91$819.00VIG
3$13,130$360.97$14,370$165.02$1.2KVIG
4$14,536$486.98$16,176$166.93$1.6KVIG
5$16,214$661.07$18,188$168.67$2.0KVIG
6$18,253$904.19$20,432$170.25$2.2KVIG
7$20,779$1,248.12$22,933$171.68$2.2KVIG
8$23,976$1,742.18$25,720$172.98$1.7KVIG
9$28,119$2,464.85$28,827$174.15$708.00VIG
10← crossover$33,632$3,544.59$32,288$175.21+$1.3KFSPKF

FSPKF vs VIG: Complete Analysis 2026

FSPKFStock

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers Airvo 2, a humidified nasal high flow system; Optiflow, a nasal high flow therapy; and F&P 850 System, a noninvasive and invasive ventilation system. In addition, it provides infant respiratory products, such as resuscitation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

Full FSPKF Calculator →

VIGETF

Seeks to track the performance of the S&P U.S. Dividend Growers Index.Passively managed, full-replication approach.Fund remains fully invested.Large-cap equity, emphasizing stocks with a record of growing their dividends year over year.Low expenses minimize net tracking error.With respect to 75% of its total assets, the fund may not: (1) purchase more than 10% of the outstanding voting securities of any one issuer or (2) purchase securities of any issuer if, as a result, more than 5% of the fund’s total assets would be invested in that issuer’s securities; except as may be necessary to approximate the composition of its target index. This limitation does not apply to obligations of the U.S. government or its agencies or instrumentalities.

Full VIG Calculator →
📬

Get this FSPKF vs VIG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FSPKF vs SCHDFSPKF vs JEPIFSPKF vs OFSPKF vs KOFSPKF vs MAINFSPKF vs DGROFSPKF vs NOBLFSPKF vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.